Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02013154
Title A Study of DKN-01 in Combination With Paclitaxel
Acronym P102
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Leap Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Cedars Sinai Medical Care Foundation Los Angeles California 90025 United States Details
Smilow Cancer Hospital at Yale - New Haven New Haven Connecticut 06520 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Massachusetts General Hospital Boston Massachusetts 02215 United States Details
Duke University Durham North Carolina 27710 United States Details
Tennessee Oncology / Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Vanderbilt University / VICC Nashville Tennessee 37232 United States Details
Mary Crowley Cancer Center Dallas Texas 75251 United States Details
CTRC @ The University of Texas Health Science Center at San Antonio San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field